Internal Reference Number: FOI_9674
Date Request Received: 02/10/2026 00:00:00
Date Request Replied To: 23/10/2026 00:00:00
This response was sent via: By Email
Request Summary: Oncology diagnosis and treatment questions
Request Category: Companies
| Question Number 1: I would like to formally request the information outlined below under the Freedom of Information Act. To help ensure the data can be interpreted accurately, I would be grateful if responses could be provided in a structured format, preferably as a table or excel file with each question (or question number) and corresponding answer shown on a separate row. Where possible, please provide responses as numerical values rather than textual descriptions. Oncology diagnosis and treatment questions a: How many patients have been diagnosed with non-small cell lung cancer in the latest 6 months? b: Of those, how many have been treated with Pembrolizumab? c: Of those, how many have been treated with Nivolumab? d: Of those, how many have been treated with Cemiplimab? e: Of those, how many have been treated with Atezolizumab? f: Of those, how many have been treated with Durvalumab? g: Of those, how many have been treated with Ipilimumab? | |
| Answer To Question 1: Q1a. <=5 b: Of those, how many have been treated with Pembrolizumab? less than 5 c: Of those, how many have been treated with Nivolumab? 0 d: Of those, how many have been treated with Cemiplimab? 0 e: Of those, how many have been treated with Atezolizumab? 0 f: Of those, how many have been treated with Durvalumab? 0 g: Of those, how many have been treated with Ipilimumab? 0 | |
| Question Number 2: a: How many patients have been diagnosed with melanoma in the latest 6 months? b: Of those, how many have been treated with Pembrolizumab? c: Of those, how many have been treated with Nivolumab? d: Of those, how many have been treated with Ipilimumab? e: Of those, how many have been treated with Relatlimab + nivolumab? f: Of those, how many have been treated with Talimogene laherparepvec? g: Of those, how many have been treated with Aldesleukin? | |
| Answer To Question 2: Q2a. 112 Not treated with systemic treatment at this Trust so question b onwards zero | |
| Question Number 3: a: How many patients have been diagnosed with head and neck squamous cell carcinoma in the latest 6 months? b: Of those, how many have been treated with Pembrolizumab? c: Of those, how many have been treated with Nivolumab? | |
| Answer To Question 3: Q3a. 22 Not treated with systemic treatment at this Trust so question b onwards zero | |
| Question Number 4: a: How many patients have been diagnosed with triple-negative breast cancer in the latest 6 months? b: Of those, how many have been treated with Pembrolizumab? c: Of those, how many have been treated with Atezolizumab? | |
| Answer To Question 4: Q4a. Breast Cancer = 153, unable to report how many are triple-negative a: How many patients have been diagnosed with triple-negative breast cancer in the latest 6 months? b: Of those, how many have been treated with Pembrolizumab? Less than 5 c: Of those, how many have been treated with Atezolizumab? 0 | |
| Question Number 5: a: How many patients have been diagnosed with cervical cancer in the latest 6 months? b: Of those, how many have been treated with Pembrolizumab? | |
| Answer To Question 5: Q5a. <=5 b: Of those, how many have been treated with Pembrolizumab? <5 | |
| Question Number 6: a: How many patients have been diagnosed with endometrial cancer in the latest 6 months? b: Of those, how many have been treated with Pembrolizumab? c: Of those, how many have been treated with Dostarlimab? | |
| Answer To Question 6: Q6a. 26 b: Of those, how many have been treated with Pembrolizumab? <5 c: Of those, how many have been treated with Dostarlimab? 0 | |
| Question Number 7: a: How many patients have been diagnosed with cutaneous squamous cell carcinoma in the latest 6 months? b: Of those, how many have been treated with Cemiplimab? | |
| Answer To Question 7: Q7a. 226 Not treated with systemic treatment at this Trust so question b onwards zero | |
| Question Number 8: a: How many patients have been diagnosed with small cell lung cancer in the latest 6 months? b: Of those, how many have been treated with Serplulimab? c: Of those, how many have been treated with Atezolizumab? d: Of those, how many have been treated with Durvalumab? | |
| Answer To Question 8: Q8a. 10 b: Of those, how many have been treated with Serplulimab? 0 c: Of those, how many have been treated with Atezolizumab? 0 d: Of those, how many have been treated with Durvalumab? 0 | |
| Question Number 9: a: How many patients have been diagnosed with Merkel cell carcinoma in the latest 6 months? b: Of those, how many have been treated with Avelumab? | |
| Answer To Question 9: Q9a. 0 b: Of those, how many have been treated with Avelumab? 0 | |
| To return to the list of all the FOI requests please click here |
Our staff at 麻豆国产 District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
